AZM-134

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAZM-134
Drug Alias Nameglucagon-like peptide-1 mimetics (Alizyme)GLP-1 mimetics (Alizyme)AZM-134AZM-133
ClassificationSmall molecules
Mechanisms of ActionGlucagon-like peptide 1 receptor modulatorsGlucagon-like peptide 1 receptor antagonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlizyme
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImperial College School of MedicineAlizymeAcambis
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A